You have 9 free searches left this month | for more free features.

Condition

Mucopolysaccharidosis II (3)

Overall Status

Recruiting (2)

Enrolling by invitation (1)

Sign in for free

Phase

phase 2/phase 3 (2)

phase 1/phase 2 (1)

Sponsor

Denali Therapeutics Inc. (3)

Collaborator

Intervention

dnl310 (3)

idursulfase (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

dnl310

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Mucopolysaccharidosis II Trial in Cincinnati (DNL310)

Enrolling by invitation

Mucopolysaccharidosis II

DNL310

Cincinnati, Ohio

Cincinnati Children's Hospital Medical Center

Oct 10, 2023

Mucopolysaccharidosis II Trial in Netherlands, United States (DNL310)

Recruiting

Mucopolysaccharidosis II

DNL310

Oakland, California
+4 more

Nov 14, 2022

Mucopolysaccharidosis II Trial in Oakland, Chapel Hill (DNL310, Idursulfase)

Recruiting

Mucopolysaccharidosis II

DNL310
Idursulfase

Oakland, California
+11 more

Jan 9, 2023